Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06028646
Other study ID # 22-01279
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 10, 2023
Est. completion date June 30, 2024

Study information

Verified date November 2023
Source NYU Langone Health
Contact Soumia Hammouda
Phone 347-204-3293
Email Soumia.Hammouda@nyulangone.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this pilot interventional study is to evaluate the use of Dynamic Airway Computed Tomography (DA-CT) for diagnosis of tracheomalacia in children 0-18 years for whom flexible bronchoscopy has been performed. The primary aims are to evaluate the diagnostic accuracy, image quality, and radiation exposure of DA-CT as a potential noninvasive alternative to the gold standard of flexible bronchoscopy in the diagnosis of tracheomalacia. The results from this pilot study will help to estimate sample size for a larger-scale study with more precise estimates of DA-CT diagnostic potential.


Recruitment information / eligibility

Status Recruiting
Enrollment 25
Est. completion date June 30, 2024
Est. primary completion date June 30, 2024
Accepts healthy volunteers No
Gender All
Age group 0 Years to 18 Years
Eligibility Inclusion Criteria: - Participants 0-18 years old, with - Clinically indicated flexible bronchoscopy has been performed Exclusion Criteria: - Pregnancy or breastfeeding - Unable to undergo CT scanning without sedation - Patients with tracheostomy

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Dynamic Airway CT scan (DA-CT)
Patient will be asked to perform movements during the scan.

Locations

Country Name City State
United States Fink Children's Ambulatory Center/Hassenfeld Children's Center New York New York
United States Tisch Hospital New York New York

Sponsors (1)

Lead Sponsor Collaborator
NYU Langone Health

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Severity of dynamic narrowing on Flexible Bronchoscopy Video recordings and images will be deidentified and reviewed by pediatric pulmonologists and scores averaged.
Severity of dynamic narrowing will be classified as follows: mild: 50%-74%, moderate: 75%-89%, severe: >90%.
Through study completion, an average of 1 year
Primary Severity of Maximal Airway Change (MAC) on DA-CT Severity of MAC will be classified as follows: mild: 33%-49%, moderate: 50%-66%, severe: >67%.
This outcome will be measured using the following equation:
MAC = tracheal cross-sectional (CSA) at narrowed segment in inspiration/CSA of trachea at thoracic inlet in inspiration
Through study completion, an average of 1 year
Primary Severity of Excessive dynamic airway collapse (EDAC) on DA-CT Severity of EDAC will be classified as follows: mild: 50%-74%, moderate: 75%-89%, severe: >90%.
This outcome will be measured using the following equation:
EDAC = CSA at airway segment in expiration/CSA at same location in inspiration
Through study completion, an average of 1 year
Secondary Contrast-to-noise-ratio (CNR) of DA-CT scanners This outcome will be measured using the following equation:
CNR = (mean Hounsfield Units (HU) in the artery regions of interest (ROI) - mean HU in the tracheal air column ROI) / image noise inside the trachea.
Through study completion, an average of 1 year
Secondary Qualitative Analysis of DA-CT Image Quality based on 5-point Likert scale 5-point Likert scale will be used as follows: (1) Very Poor, (2) Poor, (3) Fair, (4) Good, (5) Excellent Through study completion, an average of 1 year
Secondary Qualitative Analysis of DA-CT image noise based on 5-point Likert scale 5-point Likert scale will be used as follows: (1) Very Poor, (2) Poor, (3) Fair, (4) Good, (5) Excellent Through study completion, an average of 1 year
Secondary Qualitative Analysis of DA-CT delineation of large airways based on 5-point Likert scale 5-point Likert scale will be used as follows: (1) Very Poor, (2) Poor, (3) Fair, (4) Good, (5) Excellent Through study completion, an average of 1 year
Secondary Qualitative Analysis of DA-CT delineation of small airways based on 5-point Likert scale 5-point Likert scale will be used as follows: (1) Very Poor, (2) Poor, (3) Fair, (4) Good, (5) Excellent Through study completion, an average of 1 year
Secondary Qualitative Analysis of DA-CT noise texture based on 5-point Likert scale 5-point Likert scale will be used as follows: (1) Very Poor, (2) Poor, (3) Fair, (4) Good, (5) Excellent Through study completion, an average of 1 year
Secondary Radiation exposure of DA-CT scanners The effective dose (in mSv) will be automatically calculated with tissue weighting factors Through study completion, an average of 1 year
See also
  Status Clinical Trial Phase
Suspended NCT02949414 - A Study to Assess the Safety, Tolerability and Potential Efficacy of a Tracheal Replacement Consisting of a Tissue-engineered Tracheal Scaffold With Seeded Mesenchymal Cells Phase 1
Not yet recruiting NCT06409299 - Enhancing Lung Health in Kids With Structural Lung Damage and Malformations: Azithromycin (AZI) for Airway Infection Prevention Phase 3
Completed NCT00536315 - Tracheal Mechanics During Bronchoscopy N/A
Completed NCT00550602 - Tracheobronchomalacia: Treatment Outcomes N/A
Not yet recruiting NCT06335862 - Primary Posterior Tracheopexy Prevents Tracheal Collapse N/A